John M. Schaus

2.2k citations

50 papers · 1.6k indexed · h-index 24

Toxicology top 1%
- Forensic Toxicology and Drug Analysis 6
Cellular and Molecular Neuroscience top 2%
- Neurotransmitter Receptor Influence on Behavior 16
- Neuroscience and Neuropharmacology Research 10
Pharmacology top 2%
- Cannabis and Cannabinoid Research 11
Endocrine and Autonomic Systems top 10%
Biological Psychiatry top 10%
Molecular Biology
- Receptor Mechanisms and Signaling 8
- Nicotinic Acetylcholine Receptors Study 7
- Chemical Synthesis and Analysis 5
Organic Chemistry
- Chemical synthesis and alkaloids 6

Co-authors: Lee A. Phebus Philip Seeman Christian C. Felder Paul A. Wender Susan L. Gackenheimer Donald R. Gehlert Victor W. Pike Christer Halldin
Cited by: Toxicology Cellular and Molecular Neuroscience Pharmacology
Journals: Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)
Partner nations: United States Sweden United Kingdom

In The Last Decade

John M. Schaus

47 papers receiving 1.5k citations

Peers

Countries citing papers authored by John M. Schaus

Since Specialization

Citations

This map shows the geographic impact of John M. Schaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Schaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Schaus more than expected).

Fields of papers citing papers by John M. Schaus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Schaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Schaus. The network helps show where John M. Schaus may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John M. Schaus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John M. Schaus Line = papers co-authored together John M. Schaus links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Intracellular Binding Site for a Positive Allosteric Modulator of the Dopamine D1 Receptor Molecular Pharmacology ·Xushan Wang,Beverly A. Heinz,Yuewei Qian,Abobakar Rasooli,Robert A. Gadski,Lisa S. Beavers,Sheila P. Little,Charles R. Yang,James P. Beck,Junliang Hao,John M. Schaus,Kjell Svensson,Robert F. Bruns	2018	26
2	Rapid assessment of conformational preferences in biaryl and aryl carbonyl fragments PLoS ONE ·Henry B. Wallace,John M. Schaus	2018	22
3	Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT1F receptor agonists: Evolution from bicyclic to monocyclic cores Bioorganic & Medicinal Chemistry Letters ·Deyi Zhang,María‐Jesús Blanco,Bai‐Ping Ying,Annette G. Roberts,Sidney Liang,Frantz Victor,Qi Chen,Joseph H. Krushinski,Sandra Filla,V. S. Lyutenko,Brian M. Mathes,Michael P. Cohen,Ruddy Mann,David L. Nelson,David B. Wainscott,Jin-Kee Lee,Wendy H. Gough,John M. Schaus,Yao‐Chang Xu	2015	5
4	Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats The International Journal of Neuropsychopharmacology ·Jørn Arnt,Benny Bang‐Andersen,Ben Grayson,F.P. Bymaster,Michael P. Cohen,Neil W. DeLapp,Dirk Schubotz,Mads Kreilgaard,David L. McKinzie,Joanna C. Neill,David L. Nelson,Søren Nielsen,José Luis Gordo Blanco,John M. Schaus,Louise Witten	2010	92
5	Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography European Journal of Nuclear Medicine and Molecular Imaging ·Garth E. Terry,Jussi Hirvonen,Jeih‐San Liow,Nicholas Seneca,J. Tauscher,John M. Schaus,Lee A. Phebus,Christian C. Felder,Cheryl L. Morse,Victor W. Pike,Christer Halldin,Robert B. Innis	2010	17
6	Imaging and Quantitation of Cannabinoid CB₁ Receptors in Human and Monkey Brains Using ¹⁸F-Labeled Inverse Agonist Radioligands Journal of Nuclear Medicine ·Garth E. Terry,Jussi Hirvonen,Jeih‐San Liow,Sami S. Zoghbi,Robert L. Gladding,J. Tauscher,John M. Schaus,Lee A. Phebus,Christian C. Felder,Cheryl L. Morse,Sean Donohue,Victor W. Pike,Christer Halldin,Robert B. Innis	2009	78
7	Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents NeuroImage ·Garth E. Terry,Jeih‐San Liow,Eyassu Chernet,Sami S. Zoghbi,Lee A. Phebus,Christian C. Felder,Fernando José Gómez Mendoza,John M. Schaus,Victor W. Pike,Christer Halldin,Robert B. Innis	2008	38
8	The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain Neuropsychopharmacology ·Fumihiko Yasuno,Amira K. Brown,Sami S. Zoghbi,Joseph H. Krushinski,Eyassu Chernet,J. Tauscher,John M. Schaus,Lee A. Phebus,Josiane R. O. G. Pimenta,Christian C. Felder,Robert L. Gladding,Jinsoo Hong,Christer Halldin,Victor W. Pike,Robert B. Innis	2007	63
9	Indoloxypropanolamine analogues as 5-HT1A receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Joseph H. Krushinski,John M. Schaus,Subhabrata Sen,David O. Calligaro,David L. Nelson,De An Yang,David B. Wainscott,David T. Wong	2007	10
10	Pharmacological Characterization of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Inhibitors Cellular and Molecular Neurobiology ·Christopher O Dawson,村松和彦,Steven A. Moore,John M. Schaus,Bin Liu,George G. Nomikos,Christian C. Felder	2006	43
11	[3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain Naunyn-Schmiedeberg s Archives of Pharmacology ·Virginia L. Lucaites,Joseph H. Krushinski,John M. Schaus,James E. Audia,David L. Nelson	2005	35
12	[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties Naunyn-Schmiedeberg s Archives of Pharmacology ·David B. Wainscott,Joseph H. Krushinski,James E. Audia,John M. Schaus,John M. Zgombick,Virginia L. Lucaites,David L. Nelson	2005	19
13	Preclinical Pharmacology of FMPD [6-Fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4 H-3-thia-4,9-diaza-benzo[f]azulene]: A Potential Novel Antipsychotic with Lower Histamine H1 Receptor Affinity Than Olanzapine Journal of Pharmacology and Experimental Therapeutics ·Kurt Rasmussen,Mark J. Benvenga,Frank P. Bymaster,David O. Calligaro,W. C. Taylor,Julie F. Falcone,Susan K. Hemrick-Luecke,B. Auvinet,Nicholas Moore,Laura K. Nisenbaum,John M. Schaus,Esa Ahmad,David E. Tupper,Carl PRAY,David L. Nelson	2005	18
14	Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists Bioorganic & Medicinal Chemistry Letters ·Deyi Zhang,M. Hussain,Joseph H. Krushinski,Sidney Liang,Bai‐Ping Ying,Zhang Yougao,Sean R. Dinn,David B. Wainscott,Jin-Kee Lee,Wendy H. Gough,David L. Nelson,John M. Schaus,Yao‐Chang Xu	2004	15
15	Substituted furo[3,2-b]pyridines: novel bioisosteres of 5-HT1F receptor agonists Bioorganic & Medicinal Chemistry Letters ·Brian M. Mathes,V. S. Lyutenko,John M. Schaus,Yao‐Chang Xu,David L. Nelson,David B. Wainscott,Jin-Kee Lee,Wendy H. Gough,Theresa A. Branchek,John M. Zgombick,Sandra Filla	2003	9
16	5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs Neuroreport ·Kirk W. Johnson,John M. Schaus,Margaret M. Durkin,James E. Audia,Stephen W. Kaldor,Michael E. Flaugh,Nika Adham,John M. Zgombick,Marlene L. Cohen,Theresa A. Branchek,Lee A. Phebus	1997	128
17	Autoradiographic localization of [3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain European Journal of Pharmacology ·Donald R. Gehlert,Susan L. Gackenheimer,Philip Seeman,John M. Schaus	1992	71
18	Dopamine receptors labelled by [3H] quinpirole European Journal of Pharmacology ·Philip Seeman,John M. Schaus	1991	65
19	Aporphines as antagonists of dopamine D-1 receptors Journal of Medicinal Chemistry ·John M. Schaus,M.B. Ogallo,Mark M. Foreman,Norman R. Mason,Lewis L. Truex	1990	25
20	Synthesis and pharmacology of a series of 3- and 4-(phosphonoalkyl)pyridine- and -piperidine-2-carboxylic acids. Potent N-methyl-D-aspartate receptor antagonists Journal of Medicinal Chemistry ·Paul L. Ornstein,John M. Schaus,John Whiteclay Chambers,AnnI Tuvik,J. David Leander,David T. Wong,Jonathan W. Paschal,Noel D. Jones,Jack B. Deeter	1989	49

About John M. Schaus

John M. Schaus is a scholar working on Toxicology, Cellular and Molecular Neuroscience, Pharmacology, Organic Chemistry and Pharmaceutical Science, having authored 50 papers that have together received 1.6k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (16 papers), Cannabis and Cannabinoid Research (11 papers), Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (8 papers), Nicotinic Acetylcholine Receptors Study (7 papers), Chemical synthesis and alkaloids (6 papers), Forensic Toxicology and Drug Analysis (6 papers) and Chemical Synthesis and Analysis (5 papers). The work is most often cited by research in Toxicology (126 citations), Cellular and Molecular Neuroscience (639 citations), Pharmacology (484 citations), Endocrine and Autonomic Systems (104 citations) and Biological Psychiatry (37 citations). John M. Schaus has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Lee A. Phebus, Philip Seeman, Christian C. Felder, Paul A. Wender, Susan L. Gackenheimer, Donald R. Gehlert, Victor W. Pike, Christer Halldin, Alan W. White and Joseph H. Krushinski. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, NeuroImage and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact